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Abstract
Aim: To identify the associated factors of hope during treatment in cancer patients.
Background: Hope is very important to cancer patients at all stages of the disease 
process. Hope is seen as an important coping mechanism. Most research about hope 
in cancer patients considered the end of life or in palliative care. Several and differ-
ent factors are associated with hope. It is not yet sufficiently clear which factors are 
associated with hope during the treatment.
Design: A systematic literature review of quantitative empirical studies on hope in 
cancer patients during treatment.
Data Sources: Search in MEDLINE (PubMed interface), CINAHL (EBSCO interface), 
Psychinfo and Cochrane (January 2009–December 2018).
Review Methods: Empirical quantitative studies were included regardless of the dis-
ease stage, written in English or Dutch, measuring hope from the perspective of cancer 
patients. Two authors independently screened all the studies and assessed their quality.
Results: Thirty-three studies were included. Positive relationship has been established 
between hope and quality of life, social support, spiritual and existential well-being. 
Hope appears to be negatively associated with symptom burden, psychological distress 
and depression. There appears to be no relationship between hope and demographic 
and clinical variables. The relationship between anxiety and hope remains unclear.
Conclusions: Hope primarily seems to be a process that takes place in a person's 
inner being rather than being determined from outside.
Impact: Health professionals may want to focus on the meaning of hope for cancer 
patients in relation to the associated factors. A better understanding of the meaning of 
hope during treatment can be of great value in supporting cancer patients with regard 
to treatment decisions, psychosocial support, the experienced quality of life and symp-
tom burden and any wishes they may have with regard to advanced care planning.
K E Y W O R D S
associated factors, cancer patients, cancer treatment, hope, literature review, neoplasms, 
nursing, patients perspective, quantitative research, systematic review
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1  | INTRODUC TION
Hope is important for patients with cancer in all illness phases (Nierop-
van Baalen, Grypdonck, Van Hecke, & Verhaeghe, 2019). Although 
hope has been studied extensively, it is still not clear what exactly is 
meant by hope given that many definitions and concepts of the term 
exits (Eliott & Olver, 2009). In the literature, one frequently used defi-
nition is given by Dufault and Martocchio (1985), who describe hope 
as ‘a multi-dimensional dynamic life force characterized by a confi-
dent yet uncertain expectation of achieving a future good, which, to 
the hoping person, is realistically possible and personally significant’. 
Hope is also defined as one's belief in the capability to achieve goals, 
particularly in situations where one can influence outcomes through 
the use of personal abilities of strengths (Snyder, 2002). Hope differs 
from optimism because optimism is seen as a generalized expectancy 
for positive future outcomes, regardless of how controllable they are 
(Bryant & Cvengros, 2004; Rand et al., 2012).
Hope is a complex and multi-faceted phenomenon. Existing lit-
erature does not provide a clear explanation of factors associated 
with hope. This paper focuses on associated factors of hope during 
treatment. A better understanding of these related factors will help 
health professionals to attune their care.
1.1 | Background
Worldwide, over 43 million patients are living with cancer (WHO, 
2018). Most patients in this group receive some form of treatment. 
Two concepts are generally used to describe the treatment goals: 
 curative and palliative treatments. Curative treatments are treat-
ments aimed at curing the disease, which means that the patient's 
survival will not be limited by their current cancer diagnosis. Palliative 
or life-extending treatments are treatments where the intention is 
to prolong life as long as possible, although the patient is likely to 
die from the disease in the end. Palliative treatment also means that 
the treatment is aimed at improving the patient's comfort and thus 
improving their quality of life (Neugut & Prigerson, 2017). Both mean-
ings of palliative treatment will be used in this paper.
A cancer diagnosis has an enormous impact. The awareness of 
the finiteness of life and the uncertainty that results from it can 
cause an existential crisis (Grypdonck, 2005). Many cancer patients 
respond to this existential crisis by nurturing hope. The hope is 
prominent and is also noticed by health professionals (Grypdonck, 
2005). Many professionals feel uneasy when a patient expresses 
hope that goes (far) beyond the prognosis that has been communi-
cated to them (Nierop-van Baalen et al., 2019).
In the study on the meaning of hope for patients with cancer in 
the palliative phase (N = 76), Nierop-van Baalen, Grypdonck, Hecke, 
and Verhaeghe (2016) found that most patients hope because they 
feel they have no other choice and they experience that life without 
hope would have no quality or would be unbearable. Hope is seen 
as an important coping mechanism (Ebright & Lyon, 2002; Felder, 
2004; Folkman, 2010). Patients feel beaten down, but not broken. 
Hope gives them resilience (Nierop-van Baalen et al., 2016). Hope 
has an important meaning for cancer patients and is associated with 
several factors. Qualitative literature also shows that patients can 
use several strategies to increase hope, especially when they do 
not have strong sources, such as positive feedback from doctors. 
Patients with cancer need hope to live their lives (Chi, 2007; Nierop-
van Baalen et al., 2016; Salander, Bergknut, & Henriksson, 2014).
Several studies provide insight into hope in cancer patients and 
show that hope can be influenced by sociodemographic factors 
(Vellone, Rega, Galetti, & Cohen, 2006), psychological states (anxi-
ety, depression, self-esteem) (Rustøen, Wiklund, Hanestad, & Moum, 
1998), social support (Mattioli, Repinski, & Chappy, 2008), spiritu-
ality/religiosity and symptoms (Benzein & Berg, 2005) In addition, 
hope has been found to enhance coping adjustment and well-being 
(Vellone et al., 2006). These studies, however, include only a small 
proportion of patients, or focus only on a few variables and spe-
cific patient groups. In recent years, much research has been done 
into hope near the end of life (Clayton, Butow, Arnold, & Tattersall, 
2005; Eliott & Olver, 2002, 2007, 2009; Kylmä, Duggleby, Cooper, & 
Molander, 2009; Olsman, Leget, Onwuteaka-Philipsen, & Willems, 
2014; Olsson, Östlund, Strang, Grassman, & Friedrichsen, 2011). 
Little is written about hope and cancer patients during treatment 
and currently, an overview of what factors associating with hope 
during treatment is lacking. This study will therefore answer the 
following question: what factors are associated with hope in cancer 
patients during treatment?
2  | THE RE VIE W
2.1 | Aims
The aim of this review was to provide an overview of what is known 
about the associating factors of hope during treatment of cancer 
patients.
2.2 | Design
A systematic review of empirical quantitative studies was conducted 
according to the procedure of the Cochrane guidelines (Higgins et al., 
2019). This systematic review was reported in accordance with the 
PRISMA statement (Moher et al., 2015) and the additional reporting 
guideline for synthesis without meta-analysis in systematic reviews 
(Campbell et al., 2020).
2.3 | Search methods
2.3.1 | Identification of studies for inclusion
We systematically searched the MEDLINE (PubMed interface), 
CINAHL (EBSCO interface), Psychinfo and Cochrane databases from 
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1 January 2009–31 December 2018. A coherent search strategy was 
designed where MESH terms were combined with 'free text' terms: 
hope (e.g. hopeful, hoping, optimism) and cancer (e.g. neoplasm, 
tumour) and anticancer (e.g. chemotherapy, radiotherapy, anti-tu-
mour). Search terms that represent the same concept were com-
bined with the Bolean operator OR. The concepts were combined 
with the Bolean operator AND. The search strategy was designed 
for MEDLINE (PubMed interface) shown in Table 1 and subsequently 
adapted for the other databases. Also, the reference lists of the se-
lected studies were manually searched to find additional relevant 
studies. No additional studies were added after this search.
2.3.2 | Eligibility criteria
We included empirical quantitative studies on hope in cancer 
patients during treatment regardless of the stage of the disease, 
written in English or Dutch, published over the past decade, con-
sidering patients of 18 years or older and receiving some form of 
treatment (such as surgery, chemotherapy, targeted therapy, immu-
notherapy, radiotherapy and/or hormonal therapy). Relevant stud-
ies also concerned studies that measure hope from the perspective 
of cancer patients. We excluded cancer patients who did not or no 
longer received treatment (e.g. survivors or patients at the end-of-
life). Our intention was to establish associations between hope and 
other variables. Therefore, studies with a qualitative design, have 
not been included in this study. Articles with a mixed methods de-
sign were included using only the quantitative results.
2.3.3 | Study selection
Two reviewers [CN, MG] used a stepwise procedure to identify 
relevant papers. First, one of the reviewers [CN] designed the 
 Concept  
Number of 
references
#1 Cancer ‘Neoplasms’[Mesh] OR neoplas*[tiab] OR neo-plas*[tiab] 
OR cancer*[tiab] OR tumour*[ti] OR ‘tumour’[tiab] OR 
tumour'*[tiab] OR tumours*[tiab] OR tumour*[tiab] OR 
oncolog*[tiab] OR carcinoma*[tiab] OR malignan*[tiab] 
OR metasta*[tiab] OR meta-stas*[tiab] OR meta-
static*[tiab] OR lymphom*[tiab]
4,046,568
#2 Hope ‘Hope’[mesh] OR ‘Optimism’[mesh] OR ‘Adaptation, 
Psychological’[mesh] OR ‘hope’[tiab] OR hope'*[tiab] 
OR hopes*[tiab] OR hopeful*[tiab] OR hoping*[tiab] 
OR hopeless*[tiab] OR optimis*[tiab] OR hhi[ti] OR 
meaning*[tiab] OR adaptation*[tiab] OR coping*[tiab]
533,239
#3 Anticancer ‘Chemoradiotherapy, Adjuvant’[Mesh] OR 
‘Radiotherapy, Adjuvant’[Mesh] OR ‘Chemotherapy, 
Adjuvant’[Mesh] OR ((adjuvant*[tiab] OR 
curativ*[tiab] OR during*[tiab] OR palliat*[tiab]) AND 
(‘Antineoplastic Agents’[Mesh] OR chemotherap*[tiab] 
OR chemo-therap*[tiab] OR chemoradiat*[tiab] 
OR chemo-radiat*[tiab] OR chemoradio*[tiab] OR 
chemo-radio*[tiab] OR radiochemotherap*[tiab] OR 
radiochemo-therap*[tiab] OR antineoplastic*[tiab] 
OR anti-neoplastic*[tiab] OR antineo-plastic*[tiab] 
OR anti-neo-plastic*[tiab] OR anticancer*[tiab] 
OR anti-cancer*[tiab] OR antitumor*[tiab] OR 
anti-tumor*[tiab] OR antitumour*[tiab] OR anti-
tumour*[tiab] OR oncolog*[tiab] OR "Surgical 
Procedures, Operative’[Mesh] OR surger*[tiab] OR 
surgical*[tiab] OR ‘surgeon’[tiab] OR surgeon'*[tiab] 
OR surgeons*[tiab] OR operati*[tiab] OR 
‘Radiotherapy’[Mesh] OR radiotherap*[tiab] OR radio-
therap*[tiab] OR radiation*[tiab] OR irradiat*[tiab] 
OR radioimmunotherap*[tiab] OR radioimmuno-
therap*[tiab] OR immunoradiotherap*[tiab] OR 
immunoradio-therap*[tiab] OR ‘Immunotherapy’[Mesh] 
OR immunotherap*[tiab] OR immuno-therap*[tiab] 
OR targeted*[tiab] OR ‘Therapeutics’[Mesh] OR 
therap*[tiab] OR thera-peutic*[tiab] OR treat*[tiab] OR 
intent*[tiab]))
256,041
#4 Search #1 AND #2 AND #3 4,700
TA B L E  1   Search strategy MEDLINE 
(PubMed interface)
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search strategy and made a first selection based on all of the titles. 
Second, the selection based on abstracts was started together for 
at least the first 60 abstracts, to gain agreement on the selec-
tion process and refinement of the inclusion criteria. Third, the 
other abstracts were independently assessed by two reviewers 
[CN, MG]. In case of uncertainty for inclusion based on abstracts, 
the full text of the articles was screened. For the assessment of 
the full-text articles, all suitable abstracts from 1 January 2009 
onwards were included on the basis of the selection criteria, and 
the ones for which it was not yet entirely clear whether they met 
the selection criteria. Subsequently, some of the full-text articles 
that had previously been rejected by the first reviewer were also 
assessed by the second reviewer [MG] to see whether these ar-
ticles were rejected in accordance with the exclusion criteria and 
for a substantiated reason. Eligibility assessment was performed 
independently by two reviewers [CN, MG] on 5% of the titles, 
20% of the abstracts and 26% of the previously rejected full-text 
articles. An inter-rater agreement of 95% on title screening, 95% 
on abstract screening and 89% on the (previously rejected) full 
texts was obtained.
2.4 | Search outcome
The search resulted in 8,649 records. Duplicates (N = 2,894) were 
excluded. Based on the selection criteria, 5,752 abstracts were 
screened and 135 full texts were retrieved and reviewed. Figure 1 
shows the flowchart of this selection. Of the 135 potentially suitable 
articles, 102 were excluded. Reasons for exclusion were as follows: 
no more treatment or in the last stage of life (N = 23), no empiri-
cal study (N = 34), qualitative design (N = 32), language other than 
English or Dutch (N = 10) and different focus of the research theme 
(N = 3).
2.5 | Quality appraisal
The Quality Assessment Tool (Vyncke et al., 2013) was used to 
determine the quality of the quantitative studies. The assessments 
concerned the full-text articles before data extraction took place. 
The Quality Assessment Tool is an adapted version of a tool de-
veloped by the Effective Public Health Practice Project (Thomas, 
Ciliska, Dobbins, & Micucci, 2004), which was used in several 
other systematic reviews (Goossens et al., 2014; Eechoud et al., 
2016; Verbrugghe, Verhaeghe, Lauwaert, Beeckman, & Hecke, 
2013). This tool assesses the overall quality of study design and 
data analysis by looking at the following items: selection and allo-
cation bias, confounders, data collection methods, withdrawal and 
drop-outs and comments on analysis. The methodological quality 
of all articles was assessed independently by two researchers [CN, 
MG]. Discrepancies in the assessments were discussed until con-
sensus was reached.
2.6 | Data abstraction
One reviewer [CN] systematically extracted the key informa-
tion related to hope in cancer patients. The data extraction ta-
bles (Table 2, Table S1) were designed to systematically show the 
following data: authors and publication date, primary aim, hope 
instrument, design/data collection/data analyses/number of par-
ticipants/setting and country/stages of disease or treatment goal/
percentage participants under treatment and variables related 
to hope. Table 2 shows the main results of the studies. Table S1 
shows all the results, de statistical tests, p-value and estimates of 
precision (Table S1).
2.7 | Data synthesis
Given to the heterogeneous nature of the results, it was not possible 
for us to perform a meta-analysis. In general, hope was measured with 
the same instruments. However, the other variables are often meas-
ured in different ways. For this reason, the data synthesis is presented 
in a narrative way. In the studies with both univariate and multivari-
ate analyses, we have seen that significant relationships with hope in 
the univariate analyses often demonstrated to be no longer significant 
in the multivariate analyses. Eight studies (3,5,7,15,19,28,29,32) only 
involved univariate analysis, so it is uncertain what determines the 
relationships between hope and other variables. For these reasons in 
this results section only the results from the multivariate analyses are 
described. The results from the studies with multivariate analyses and 
only univariate analyses can be found in Table 2 and Table S1. We in-
cluded the results from a significant level of p ≤ .05.
3  | RESULTS
3.1 | Description of included studies
A total of 33 quantitative studies were included. Table 3 shows the 
characteristics of the studies. Most studies were cross-sectional, 
originated in Asia (N = 14), America (N = 10), Europe (N = 8) and fo-
cused on curative and palliative treatment (N = 16) or solely palliative 
treatment (N = 7) of solely curative treatment (N = 3). Seven stud-
ies did not mention the treatment goal (curative or palliative). Sample 
size varied from 44–600 participants. Most studies (N = 25) included 
multivariate analyses. Some studies involved only univariate analyses 
(N = 8).
3.2 | Definitions and assessments of hope
Several measuring tools were used to measure hope. Most studies 
measured hope using the Hope Herth Index (HHI) (N = 17), the State 
Hope Scale (SHS) (N = 12) or the Herth Hope Scale (HHS) (N = 1). 
     |  5NIEROP-VAN BAALEN Et AL.
One study used the Mini Mental Adjustment to Cancer scale (MAC) 
and two a self-designed questionnaire (Table 4 for the detail infor-
mation about the hope instruments).
3.3 | Methodological quality of the included studies
Details of the assessment of the quality of the included studies are 
presented in Table 5. In general, the quality of the quantitative and 
mixed methods articles was assessed as medium to strong. None of 
the studies were excluded on the basis of their quality.
3.4 | Synthesis of the results
This review shows that hope is associated with different factors. The 
factors associated with hope are described by means of the following 
clusters: hope and demographic data, clinical variables, depression, 
anxiety, social support, other psychological variables, spiritual-
ity, quality of life and physical symptom load. Table 6 presents an 
overview of the associated variables with hope in relation to the 
studies, based on the multivariate analyses.
3.4.1 | Hope and demographic data
No relationship was found between age and hope in nine stud-
ies (1,12,17,18,22–26). However, one study (9) noted that the total 
hope score had an inverse relationship to age. Newly diagnosed 
patients aged 18–64 reported higher scores than participants aged 
65 or over. In seven studies (1,12,17,18,22,23,25) were no differ-
ences between hope among male and female patients. However, 
male patients scored higher on hope than female patients, in one 
study (9).
No relationship between hope and level of education was shown 
in five studies (17,18,22,25,26). However, one study (6) found a 
positive relationship between level of education and total hope 
scores and one study found a negative relation (23). Six studies 
(1,9,17,18,22,25) showed no relationship between hope and being 
married. One study (26) concluded that the total hope score was 
F I G U R E  1   Flow chart [Colour figure 
can be viewed at wileyonlinelibrary.
com]
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database searching
(N = 8,649)
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of duplicates (N = 2,894)
Records screened
(N = 5,755)
Records excluded based 
on title/abstract
(N = 5,620)
Full-text articles assessed 
for eligibility (N = 135) Full-text articles excluded, with reasons (N = 102): 
End of life/no treatment
(N = 23)
No empirical study (N = 34)
Qualitative design 
(N = 32)
No English or Dutch language 
(N = 10)
Other focus (N = 3)Studies included 
(N = 33)
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positively related to being married. One study (24) showed that 
higher hope scores of patients (with breast cancer) and their part-
ners predict greater marriage satisfaction.
3.4.2 | Hope and clinical variables
No relationship was found between hope and the type of cancer 
in four studies (18,23,25,26) or type of treatment in three studies 
(1,25,26). Three studies (18,22,23) did not show any relationship be-
tween hope and the different stages of the disease.
3.4.3 | Hope and depression
Several measuring tools were used to measure depression. Two stud-
ies (10,22) used the Hospital anxiety and depression scale (HADS), 
another two studies (12,15) the brief symptom inventory (BSI), one 
study (2) the Center for Epidemiologic Studies Depression Scale and 
one study (9) asked patients if they feel depressed. Although, the dif-
ferent use of measuring tools, a negative relationship between hope 
and depression was demonstrated in five studies, using validated 
measuring tools. However, one study (12) found a negative relation-
ship between hope and depression for the group of female patients 
of 55 years and older and not for the group of female patients aged 
54 or younger. No relationship was found between hope and feeling 
depressed in newly diagnosed patients (9).
3.4.4 | Hope and anxiety
Anxiety was measured by different measuring tools. Two studies 
(10,22) used the HADS, one study (15) the BSI, one study (13) the 
mental adjustment to cancer scale which measuring anxious preoccu-
pation and two times patients were asked if they feel anxious or wor-
ried (9,17). Hope and anxiety were negatively related to the overall 
hope scores in three studies (13,15,17). However, no relationship was 
demonstrated in three studies (9,10,22), whereby anxiety was meas-
ured by HADS (two times) and asked patients if they feel anxious.
3.4.5 | Hope and social support
However, social support was measured by different measuring tools, 
all the eight studies (1,2,6,12,17,18,20,21) found a positive relation-
ship between hope and social support. The used measuring tools for 
social support were as follows: Perceived social support scale (PSSS) 
(2,20); Cancer perceived agents of social support (12), Personal re-
source questionnaire (18) and the use of a self-developed question-
naire (1,6,17). One study (18) showed that social support was the 
most influential factor on the strength of hope found. Another study 
(21) showed that patients had a stronger sense of hope when they 
received treatment and care and were able to share their experi-
ences with others.
3.4.6 | Hope and other psychological factors
Patients with high hope scores scored lower on psychological dis-
tress (23,25). Hope having a buffering role in the relationship be-
tween health status and psychological distress (25).
Hope was positively related to courage related strategies, self-ef-
ficacy and resilience (33). A higher degree of psychological adapta-
tion measured using the Mood State Standard Form appeared to be 
related to higher patient hope scores (24). One study (21) concluded 
that positive thinking about others was a factor that gave patients a 
stronger sense of hope. For patients participating in phase 1 trials 
(4), hope was related to tenacity, flexible coping and internal locus of 
control. Hope turned out to be negatively related to external locus of 
control (4). Hope was positively related to task-oriented coping and 
social diversion (1).
TA B L E  3   Characteristics of the included studies (N = 33)
Study characteristics N
Type of study
Cross-sectional 28
Prospective cohort 2
Randomized controlled trial 2
Longitudinal 1
Data analyses
Multivariate 25
Only univariate 8
Treatment intent
Curative 3
Palliative 7
Curative and palliative 16
Not reported 7
Continent
Asia 14
America 10
Europe 8
Australia 1
Hope instrument
Herth hope index 17
Herth Hope Scale 1
State Hope Scale 12
Other 3
Number of patients in study
0–100 11
101–200 11
201–300 5
>300 6
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3.4.7 | Hope and spirituality/religion
Spirituality was measured in the studies by the spiritual well-being 
scale (SWB) (14), daily spiritual experience scale (16), the system of 
belief inventory (23) and the Steinhauser Spiritual Concern Probe 
(22). Hope had a positive relationship with SWB (14,22,23). A posi-
tive relationship had also been established between hope and exis-
tential well-being (14). One study (16) showed a positive relationship 
between hope and the total score of daily spiritual experiences, the 
feeling of God's presence, the relationship with God and feeling re-
sponsible for others respectively. Religious support was the second 
most influential factor (after social support) on the strength of hope 
(18). Hope had a positive relationship with religious well-being (14), 
religiousness (23) and trust in religion (21). Hope as a mediator de-
creased the negative relationships between religious identity and 
anxiety (12). No relationship was found between hope and any reli-
gious affiliation (22).
3.4.8 | Hope and quality of life
Several measuring tools were used to measure quality of life: 
European Organization for Research and Treatment for Cancer 
Quality of Life Questionnaire (EORTC QLQ-C30) (4); Functional 
Assessment of Cancer Therapy—Bladder cancer (FACT-BI) (20); 
The Satisfaction with Life Scale (14,25). A positive relationship 
between hope and quality of life was evident from all the studies 
that investigated these aspects (4,14,20,25). Hope can be seen as 
a source that helped patients to deal (cope) with the psychologi-
cal distress associated with the disease (25). Hope was studied 
(14) as an independent variable and life satisfaction as a depend-
ent variable, they show that hope determined life satisfaction. 
A positive relationship was found between hope and perceived 
health (25).
3.4.9 | Hope and physical symptom burden
General symptoms
The total symptom load score (Edmonton Symptom Assessment 
Scale [ESAS]) was compared with the total hope score (23) and 
showed that hope had a negative relationship with the total ESAS 
score. No relationship between hope and physical complaints was 
found (25). No difference between hope and disease-focused symp-
toms had been demonstrated in lung cancer patients receiving pallia-
tive treatment (30). A negative relationship between hope and three 
treatment-oriented symptoms (dyspnoea, coughing and sore mouth) 
was found (1). The other treatment-related symptoms appropriate to 
TA B L E  4   Measuring hope as integrated in the included studies
Hope scales Score ranges Definition
Herth hope scale 
(HHS)
30 items, 4-point Likert scale (‘never applies to me’, ‘rarely applies to me’, 
‘sometimes applies to me’ and ‘always applies to me’, scored as 0, 1, 2 and 
3 respectively). 3 subscales (‘future’, ‘positive readiness and hope’ and 
‘connection with surroundings’). Total hope score between 0–90, total 
score of each subscale between 0–30. Higher scores indicate higher level 
of hope.
Dufault and Martocchio (1985): hope is 
‘a multi-dimensional dynamic life force 
characterized by a confident yet uncertain 
expectation of achieving a future good, 
which, to the hoping person, is realistically 
possible and personally significant’
Herth hope index 
(HHI)
Modified HHI
12 items, 4-point Likert scale (‘strongly disagree’ (1 point) to ‘strongly 
agree’ (4 points)
3 subscales: (a) cognitive-temporal (the perception that a positive, desired 
outcome is realistically probable in the near or distant future); (b) 
affective-behavioural (a feeling of confidence with initiation of plans to 
affect the desired outcome); (c) affiliative-contextual (the recognition of 
the interdependence and interconnectedness between self and others 
and between self and spirit). Total HHI scores range from 12–48 (higher 
scores indicate higher levels of hope).
Modified HHI: 12-items, 4-point Likert scale. 3 factors of hope: 
temporality and future, positive readiness and expectancy and 
interconnectedness. Total scores range from 12–24 (higher score indicate 
higher hope)
Dufault and Martocchio (1985)
State hope scale 
(SHS)
6 items, 8-point Likert scale (‘definitely false’ (0 points) to ‘definitely true’ 
(8 points)
2 subscales: pathway and agency (3 items each). Total score between 0 
(least hopefulness) and 8 (greatest hopefulness)
Snyder (2002): ‘Pathways thinking’ signifies 
one's perceived capabilities at generating 
workable routes to desired goals. ‘Agency 
thinking’ is the perceived capacity for 
initiating and maintaining the actions 
necessary to reach a goal
Mini mental 
adjustment to 
cancer (MAC)
8 items, 4-point Likert scale. 4 subscales: fighting spirit, positive 
redefinition, helplessness-hopelessness and anxious pre-occupation. 
Total scores between 8–32; higher scores indicate greater hope
-
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TA B L E  5   Quality assessment of quantitative studies and mixed methods study using the qualitative assessment tool (QAT) (Vyncke et al., 
2013)
QAT item
References
Selection 
biasa
Allocation 
biasb Confoudersc
Data 
collection 
methodsd
Withdrawals 
and drop-oute
Analysisf
Q1 Q2 Q3 Q4 Q5 Q6
Bando et al. (2018) Strong NA Strong Strong Strong No Yes No Yes NR Yes
Bao et al. (2019) Strong NA Strong Strong Strong P Yes Yes Yes P Yes
Beach and Dozier (2015) Strong NA NA Strong NR No Yes Yes Yes NR No
Van der Biessen, Helm, et al. 
(2018)
Strong NA Strong Strong Strong No Yes Yes Yes NR Yes
Van der Biessen, Helm, et al. 
(2018)
Strong NA Strong Strong Strong Yes Yes Yes Yes Yes Yes
Cao et al. (2017) Strong NA Strong Moderate Strong No Yes Yes Yes Yes Yes
Cripe et al. (2018) Moderate NA Moderate Strong Strong No P Yes Yes NR Yes
DeMartini et al. (2019) Strong NA Strong Strong Strong No Yes Yes Yes NR Yes
Duggleby et al. (2013) Strong Strong Moderate Strong Strong P Yes Yes Yes Yes Yes
Fischer et al. (2018) Strong NA Strong Strong Strong No P Yes Yes Yes Yes
Green et al. (2015) Weak Strong Strong Strong Strong No Yes Yes Yes Yes Yes
Hasson-Ohayon et al. (2009) Strong Strong Strong Strong Strong No Yes Yes Yes NR Yes
Hasson-Ohayon et al. (2014) Strong Strong Strong Strong Strong No Yes Yes Yes NR Yes
Jafari et al. (2010) Moderate NA Moderate Moderate NR No No Yes Yes NR Yes
Jimenez-Fonseca et al. (2018) Strong NA Strong Strong Strong No Yes Yes Yes Yes Yes
Karami and Kahrazei (2018) Moderate NA Strong Strong NR No No Yes Yes NR Yes
Kavradim et al. (2016) Strong NA Strong Strong Strong Yes Yes Yes Yes NR Yes
Khater and Alkwiese (2013) Strong NA Strong Moderate Strong No Yes Yes Yes Yes Yes
Li et al. (2016) Strong NA Strong Strong Strong No Yes Yes Yes Yes Yes
Li et al. (2017) Strong NA Strong Moderate Strong No Yes Yes Yes NR Yes
Proserpio et al. (2015) Strong NA NR Weak NR No Yes No P No NA
Rawdin et al. (2013) Strong NA Strong Strong Strong Yes Yes Yes Yes P Yes
Ripamonti et al. (2016) Strong NA Strong Strong Strong No Yes Yes Yes Yes Yes
Rock et al. (2014) Strong NA Strong Strong Strong No Yes Yes Yes Yes Yes
Rustøen et al. (2010) Moderate NA Strong Strong Strong NA Yes Yes Yes NA Yes
Schjolberg et al. (2011) Strong NA Strong Strong NR No Yes Yes Yes Yes Yes
Schofield et al. (2016) Strong Strong Strong Strong Strong No Yes Yes Yes NR Yes
Shun et al. (2011) Strong NA Weak Strong NR No Yes Yes Yes NR Yes
Soylu et al. (2016) Strong NA Strong Weak NR No Yes Yes Yes NR Yes
Steffen et al. (2018) Strong NA Strong Strong Strong No Yes Yes Yes Yes Yes
Wakiuchi et al. (2015) Moderate NA NA Strong NR P P Yes Yes NR Yes
Wnuk et al. (2012) Strong NA Weak Strong Strong No Yes Yes Yes NR Yes
Ye et al. (2018) Strong NA Strong Strong Strong Yes Yes Yes Yes Yes Yes
NA, not applicable; NR, not reported; P, partial.
aSelection bias: ‘Are individuals selected to participate in the study likely to be representative of the target population’, and ‘What is the response 
rate’. 
bAllocation bias: indication of study design. 
cConfounders: ‘Were important confounding variables mentioned’? and ‘If important confounders were mentioned, were they included in the 
analysis’? 
dData collection methods: ‘For each variable of interest, is the data collection tool clearly indicated’?, ‘Were data collection tools shown or are they 
known to be valid’? and ‘Were data collection tools shown or are they know to be reliable’? 
eWithdrawal and drop-outs: indication of withdrawal/drop-out rate. 
fAnalysis: ‘Q1: Is there a sample size calculation or power calculation’?, ‘Q2: Are characteristics of study participants extensively reported’?, ‘Q3: Are 
the main results of the statistical analysis unambiguously reported’?; ‘Q4: Are the statistical methods appropriate’?, ‘Q5: Are missing data handled in 
an appropriate way’? and ‘Q6: Are all outcome measures mentioned in the method section reported in the result section’? 
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TA B L E  6   Overview of the variables associated with hope in relation to the studies, based on multivariate analyses
Variable
Relation with hope
Positive Negative No relation Other
Demographical
Age – – Bando et al. (2018)
Hasson-Ohayon et al. (2014)
Kavradim et al. (2016)
Khater and Alkwiese (2013)
Rawdin et al. (2013)
Ripamonti et al (2016)
Rock et al. (2014)
Rustøen et al. (2010)
Schjolberg et al. (2011)
Duggleby et al. 
(2013)
Gender – – Bando et al. (2018)
Hasson-Ohayon et al. (2014)
Kavradim et al. (2016)
Khater and Alkwiese (2013)
Rawdin et al. (2013)
Ripamonti et al (2016)
Rustøen et al. (2010)
Duggleby et al. 
(2013)
Education Cao et al. (2017) Ripamonti et al (2016) Kavradim et al. (2016)
Khater and Alkwiese (2013)
Rawdin et al. (2013)
Rustøen et al. (2010)
Schjolberg et al. (2011)
–
Being married Schjolberg et al. (2011) – Bando et al. (2018)
Duggleby et al. (2013)
Kavradim et al. (2016)
Khater and Alkwiese (2013)
Rawdin et al. (2013)
Rustøen et al. (2010)
Rock et al. 
(2014)
Clinical
Type of cancer – – Khater and Alkwiese (2013)
Ripamonti et al (2016)
Rustøen et al. (2010)
Schjolberg et al. (2011)
–
Type of treatment – – Bando et al. (2018)
Rustøen et al. (2010)
Schjolberg et al. (2011)
–
Stages of disease – – Khater and Alkwiese (2013)
Rawdin et al. (2013)
Ripamonti et al (2016)
–
Depression – Bao et al. (2019)
Fischer et al. (2018)
Hasson-Ohayon et al. (2014)
Jimenez-Fonseca et al. (2018)
Rawdin et al. (2013)
Duggleby et al. (2013) –
Anxiety – Hasson-Ohayon et al., 2009
Jimenez-Fonseca et al. (2018)
Kavradim et al. (2016)
Duggleby et al. (2013)
Fischer et al. (2018)
Rawdin et al. (2013)
–
Social support Bando et al. (2018)
Bao et al. (2019)
Cao et al. (2017)
Hasson-Ohayon et al. (2014)
Kavradim et al. (2016)
Khater and Alkwiese (2013)
Li et al., 2016
Proserpio et al. (2015)
– – –
(Continues)
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postoperative treatment of lung cancer (e.g. alopecia, pain in chest, 
peripheral neuropathy, dysphagia) appeared not to be related to 
hope (1). The feeling of symptom improvement was positively re-
lated to the total hope scores (17).
Specific symptoms
There appeared to be no relationship between the total hope scores 
and pain scores (1,9,22). No relationship had been demonstrated be-
tween total hope scores and energy scores in newly diagnosed pa-
tients (9). One study (26) showed a negative relationship between 
the total hope score and total fatigue, mental fatigue and chronic 
fatigue respectively. There appeared to be no relationship between 
hope and physical fatigue. Mouth ulcers were negatively related 
to the total hope scores (17). Other symptoms (sleep disturbance, 
shortness of breath, weakness) did not appear to be related to the 
total hope scores (17).
4  | DISCUSSION
This systematic review attempts to identify factors that are associ-
ated with hope during treatment of cancer patients. A total of 33 
studies were included. Descriptive synthesis of the studies allows us 
to draw some conclusions.
Variable
Relation with hope
Positive Negative No relation Other
Other psychological
Psychological 
distress
– Ripamonti et al (2016)
Rustøen et al. (2010)
– –
Coping, courage 
related strategies, 
self-efficacy, 
resilience, 
adaptation or 
Positive thinking
Bando et al. (2018)
Van der Biessen, Helm, et al. 
(2018)
Proserpio et al. (2015)
Rock et al. (2014)
Ye et al. (2018)
– – –
Spirituality Jafari et al. (2010)
Karami and Kahrazei (2018)
Rawdin et al. (2013)
Ripamonti et al (2016)
– – –
Religion Jafari et al. (2010)
Karami and Kahrazei (2018)
Khater and Alkwiese (2013)
Rawdin et al. (2013)
Ripamonti et al (2016)
– Hasson-Ohayon et al. (2009) Proserpio et al. 
(2015)
Quality of life Van der Biessen, Helm, et al. 
(2018)
Jafari et al. (2010)
Li et al., 2016
Rustøen et al. (2010)
– – –
Symptoms
Treatment related 
symptoms 
or physical 
complaints
– Bando et al. (2018)
Ripamonti et al. (2016)
Rustøen et al. (2010)
Steffen et al. (2018)
–
Improvement of 
symptoms or 
higher physical 
functioning
Kavradim et al. (2016) – – –
Pain – – Bando et al. (2018)
Duggleby et al. (2013)
Rawdin et al. (2013)
–
Energy – – Duggleby et al. (2013) –
Total fatigue – Schjolberg et al. (2011) – –
Mouth ulcers – Kavradim et al. (2016) – –
TA B L E  6   (Continued)
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4.1 | Main findings
The results suggest that hope can be associated with different fac-
tors and that these factors may vary across the included studies. 
However, some relationships are highlighted. A positive relationship 
has been established between hope and quality of life, social sup-
port, spiritual and existential well-being respectively. Hope appears 
to have a negative relationship with symptom burden, psychologi-
cal distress and depression. There appears to be no relationship be-
tween hope and demographic and clinical variables. The relationship 
between hope and anxiety remains unclear.
Taking these results into account, it seems that external factors 
(demographic data, clinical variables) are not associated with hope. 
However, intrinsic factors, that is factors that are experienced and 
assessed by the patients themselves, such as quality of life, psycho-
logical distress and social support are associated with hope. Hope 
seems to be a process that is determined by a person's inner being 
rather than influenced from the outside.
Davis et al. (2017) also studied factors associated with hope, but 
with a focus on cancer patients in a palliative care unit. These are 
people who are further in the disease process and generally no lon-
ger receive tumour-oriented treatment. This study shows almost the 
same results: it also finds no relationship between hope and demo-
graphic and clinical variables. In the multivariate analyses, only the 
negative relationship between hope and depression appears to be 
significant. There seems to be no difference between people with 
cancer in active treatment and those with a more advanced illness. 
More research is needed to examine to what extent the findings re-
garding to the different phases in the disease process can be com-
pleted or refined.
Whether symptoms have a relationship with hope seems to de-
pend on the method by which the symptoms were measured. Davis 
et al. (2017) found a weak relationship between hope and symptom 
burden. A possible explanation offered by Davis et al. (2017) them-
selves pertains to the way the symptoms were assessed; the ESAS 
measures only the intensity of a symptom (e.g. fatigue) and does not 
make a distinction between mental or physical fatigue, tiredness, or 
weakness. An association may exist between a particular fatigue do-
main and hope as demonstrated by the study of Schjolberg, Dodd, 
Henriksen, and Rustoen (2011), included in our systematic review. 
They showed an association between hope and total fatigue, men-
tal fatigue and chronic fatigue, but not with physical fatigue. For 
patients who are only asked about the intensity of a symptom, for 
example fatigue, we do not know what type of symptom (mental 
fatigue, chronic fatigue or physical fatigue) they had in mind when 
completing this score.
Moreover, it seems to be important whether symptoms have been 
measured in curative or palliative patients. The studies that show a 
negative relationship with hope and general or specific symptoms 
are all studies that have been done in predominantly curative pa-
tients, as described in our systematic review (Bando, Onishi, & Imai, 
2018; Kavradim, Ozer, & Bozcuk, 2016; Ripamonti, Miccinesi, Pessi, 
Di Pede, & Ferrari, 2016; Schjolberg et al., 2011). In all the studies, 
hope is measured with the HHI or HHS validated for their country. 
The studies that did not show a relationship with hope and symptoms 
were done mainly in palliative patients (Steffen, Vowles, Smith, Gan, 
& Edelman, 2018) or did not mention the treatment goal (Rustøen, 
Cooper, & Miaskowski, 2010). Symptoms may play a different role in 
cancer patients who mainly undergo curative treatment, who gener-
ally have fewer symptoms due to their better performance.
Berendes et al. (2010) and Utne, Miaskowski, Bjordal, Paul, and 
Rustoen (2010) both studied palliative cancer patients and also 
demonstrated that other pain domains (such as pain interference 
with daily activities, the meaning of pain, or the affective domain 
of pain) may influence hope to a greater extent than pain intensity. 
These studies argue that symptoms should not only be measured by 
their intensity, but also by their interference with daily activities and 
the meaning it have for the patients.
A review to psychometric properties of hope scales (Redlich-
Amirav, Ansell, Harrison, Norrena, & Armijo-Olivo, 2018) shows 
that 18 hope scales exists. In the oncology, the hope scales HHI, 
HHS and SHS are used most frequently. Two other hope scales are 
developed for oncology patients, are the Miller Hope Scale and the 
Nowotny Hope Scale. These are mainly described in older literature 
(before 2000). Redlich-Amirav et al. (2018) concluded that no robust 
and valid scale exists for measuring hope; they agreed with Eliott 
and Olver (2002) that it is possible that hope is an entity that cannot 
be accurately quantified, given the extensive ways to define and un-
derstand it. Eliott and Olver (2002) suggested that hope should not 
be explained using only models or definitions, but that the meaning 
of hope should be left to the individuals themselves to determine.
Nierop-van Baalen et al. (2016) and Salander et al. (2014) ex-
plained the importance of the meaning of hope from the patients 
with cancer themselves. This process is described as ‘the work of 
hope’ (Nierop-van Baalen et al., 2016) and Salander et al. (2014) de-
scribes this as ‘a creative process for psychological survival thus been 
initiated by patients’. These both studies showed that patients cre-
ated hope themselves and used different strategies to increase their 
hope or defend it against threat, when necessary. These studies con-
firm that hope seems to be a process that is determined by a person's 
inner being rather than influenced from the outside.
4.2 | Strengths and limitations
This study has several limitations. Generalizations require caution as 
the included studies used different methods for assessing, for exam-
ple depression, anxiety, social support and spirituality. Almost all of 
the studies in this review had a cross-sectional design, which does 
not allow us to identify the direction of the relationship between 
hope and the associated factors. Consequently, we can say very lit-
tle about the course of hope over time. In addition, one study (Rock, 
Steiner, Rand, & Bigatti, 2014) have low statistical power, meaning 
that their results should be interpreted with caution. The included 
studies reflect a diverse range of countries and societies. This can 
be a strength, but might also account for some of the differences, 
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for example strength of the influence of spirituality was seen in 
countries that may have a stronger religious basis (e.g. Iran and 
Israel)—these findings may be less generalizable. As described be-
fore, the study is based on quantitative studies with predominantly 
cross-sectional design. That is why we cannot say much about the 
course of hope over time, the process, meanings and its dynamics. 
Qualitative studies on hope over time can complete this picture.
The strength of this systematic review is demonstrated by the 
design allowing for a comprehensive systematic search with the 
use of a well-designed search filter. Four major healthcare data-
bases were searched. Reference lists of the included articles were 
screened for additional articles and no additional studies were 
added after this search. Large numbers of abstracts and published 
articles were screened or read. The different steps of the selection 
process and the assessment of the quality of the articles were rig-
orously done by two independent reviewers. Most studies exam-
ined hope using the same measuring tools, that is Snyders' hope 
scale and the Herth Hope Index, which enhances the validity of 
the study. The HHI and the SHS are the two hope scales that have 
been evaluated the most (Redlich-Amirav et al., 2018). Another 
strength of this systematic review, is that it only describes the re-
sults of the multivariate analyses. This enables us to interpret the 
relationships between the variables and hope with more certainty.
4.3 | Implication for practice and further research
An important finding of this review is that the related factors are 
very diverse. It seems that the factors associating with hope are 
mainly factors that are experienced and assessed by the patients 
with cancer themselves. These are factors such as social support, 
quality of life, existential and SWB, symptom burden, psychologi-
cal distress and depression. These factors are typically given mean-
ing by the patients themselves. Social support, for example, is not 
about how many patients experience support, but that this support 
has real meaning for them. This may become even clearer in the 
case of experienced symptom burdens and psychological distress, 
where only the patients themselves can make clear to the health 
professionals what impact and meaning these symptoms have for 
them. For nurses who work with patients with cancer during treat-
ments, it is important to know that psychological distress diminishes 
hope and that patients have or could develop their own strategies 
to increase the hope. Health professionals are challenged to face 
and address patients’ perceptions of hope and discussing this with 
them to explore which strategies can be helpful for them. This can 
be a valuable intervention and this approach may lead to decreased 
psychological distress and better quality of life for cancer patients.
More research is needed to find out more about the meaning of 
hope, the process of hope, its dynamics and the related factors. At 
the moment we do not know sufficiently whether hope has a differ-
ent meaning for patients in the palliative phase than for patients in 
the curative phase. Although there are specific studies on hope in 
the palliative phase, the studies that have included both patients with 
curative treatments and those with palliative treatments did not anal-
yse the results separately. More insight into the differences between 
these two groups can help health professionals to provide tailored 
care. This also applies to specific treatment phases, around diagno-
sis, during treatment, upon completion of treatment, after stopping 
treatment, for the 'survivors' and for patients who experience a re-
lapse. This knowledge can be of great value in supporting patients 
with regard to treatment decisions, psychosocial support, the experi-
enced quality of life, symptom burden and any wishes they may have 
with regard to advanced care planning. Future studies are needed to 
study the direction of causality between hope and the variables.
5  | CONCLUSIONS
This literature review of associated factors of hope in cancer pa-
tients receiving treatment shows that hope seems to be positively 
related mainly by intrinsic factors, such as perceived health, quality 
of life, social support and existential and SWB. Hope is negatively 
related by experienced symptoms, psychological distress and de-
pression. Demographic and clinical factors are not related to hope. 
Health professionals may want to focus on the meaning of hope for 
cancer patients in relation to these factors.
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